| Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19 S Sciascia, F Aprà, A Baffa, S Baldovino, D Boaro, R Boero, S Bonora, ... Clin Exp Rheumatol 38 (3), 529-532, 2020 | 374 | 2020 |
| The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years G Guaraldi, A Malagoli, A Calcagno, C Mussi, BM Celesia, F Carli, ... BMC geriatrics 18, 1-10, 2018 | 158 | 2018 |
| Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era E Cerrato, F D'Ascenzo, G Biondi-Zoccai, A Calcagno, S Frea, ... European heart journal 34 (19), 1432-1436, 2013 | 145 | 2013 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 123 | 2022 |
| High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis F D'Ascenzo, E Cerrato, A Calcagno, W Grossomarra, F Ballocca, ... Atherosclerosis 240 (1), 197-204, 2015 | 120 | 2015 |
| Cardiovascular disease in HIV patients: from bench to bedside and backwards E Cerrato, A Calcagno, F D'ascenzo, G Biondi-Zoccai, M Mancone, ... Open heart 2 (1), e000174, 2015 | 114 | 2015 |
| Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system A Calcagno, G Di Perri, S Bonora Clinical pharmacokinetics 53, 891-906, 2014 | 81 | 2014 |
| Ultrasensitive assessment of residual HIV viraemia in HAART‐treated patients with persistently undetectable plasma HIV‐RNA: A cross‐sectional evaluation S Bonora, E Nicastri, A Calcagno, D Gonzalez de Requena, G D'Ettorre, ... Journal of medical virology 81 (3), 400-405, 2009 | 71 | 2009 |
| Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients M Trunfio, F Venuti, F Alladio, BM Longo, E Burdino, F Cerutti, V Ghisetti, ... Viruses 13 (2), 281, 2021 | 69 | 2021 |
| Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control A Calcagno, M Simiele, MC Alberione, M Bracchi, L Marinaro, S Ecclesia, ... Clinical Infectious Diseases 60 (2), 311-317, 2015 | 65 | 2015 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 63 | 2019 |
| Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis S Gili, W Grosso Marra, F D'Ascenzo, E Lonni, A Calcagno, M Cannillo, ... European heart journal 37 (48), 3600-3609, 2016 | 63 | 2016 |
| Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function A Calcagno, D Gonzalez De Requena, M Simiele, A D'Avolio, MC Tettoni, ... Antimicrobial agents and chemotherapy 57 (4), 1840-1843, 2013 | 62 | 2013 |
| Co-infection with other respiratory pathogens in COVID-19 patients A Calcagno, V Ghisetti, E Burdino, M Trunfio, T Allice, L Boglione, ... Clinical Microbiology and Infection 27 (2), 297-298, 2021 | 59 | 2021 |
| HIV infection and primary prevention of cardiovascular disease: lights and shadows in the HAART era F Ballocca, S Gili, F D’Ascenzo, WG Marra, M Cannillo, A Calcagno, ... Progress in cardiovascular diseases 58 (5), 565-576, 2016 | 59 | 2016 |
| Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T> C polymorphism M Siccardi, A D'Avolio, S Nozza, M Simiele, L Baietto, FR Stefani, D Moss, ... Pharmacogenetics and genomics 20 (12), 759-765, 2010 | 58 | 2010 |
| Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients A Calcagno, C Atzori, A Romito, D Vai, S Audagnotto, ML Stella, ... Journal of neurovirology 22, 88-92, 2016 | 52 | 2016 |
| Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment A D'Avolio, A Ciancio, M Siccardi, A Smedile, L Baietto, M Simiele, ... Therapeutic drug monitoring 34 (2), 165-170, 2012 | 52 | 2012 |
| Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization? I Motta, A Calcagno, S Bonora Expert opinion on drug metabolism & toxicology 14 (1), 59-82, 2018 | 50 | 2018 |
| Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study S Nozza, A Malagoli, L Maia, A Calcagno, E Focà, G De Socio, S Piconi, ... Journal of Antimicrobial Chemotherapy 72 (10), 2879-2886, 2017 | 49 | 2017 |
Antonio D'AvolioUniversity of Turin, Medical Sciences Dpt., Lab. Clinical Pharmacology and Pharmacogeneticsبريد إلكتروني تم التحقق منه على unito.it
